180 Wealth Advisors LLC Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

180 Wealth Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 42.6% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 3,952 shares of the exchange traded fund’s stock after purchasing an additional 1,181 shares during the quarter. 180 Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $375,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Envestnet Asset Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 5.8% during the third quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock valued at $9,201,000 after purchasing an additional 6,884 shares in the last quarter. Mariner LLC lifted its stake in SPDR S&P Biotech ETF by 6.3% during the 3rd quarter. Mariner LLC now owns 33,396 shares of the exchange traded fund’s stock valued at $2,439,000 after acquiring an additional 1,970 shares during the period. Synovus Financial Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 9.3% during the 3rd quarter. Synovus Financial Corp now owns 5,018 shares of the exchange traded fund’s stock valued at $366,000 after acquiring an additional 429 shares during the last quarter. Ironwood Investment Counsel LLC bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $269,000. Finally, Alerus Financial NA raised its holdings in shares of SPDR S&P Biotech ETF by 0.6% during the third quarter. Alerus Financial NA now owns 54,655 shares of the exchange traded fund’s stock valued at $3,991,000 after purchasing an additional 349 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7 %

NYSEARCA:XBI traded down $0.64 during trading hours on Friday, hitting $92.22. 2,629,006 shares of the stock traded hands, compared to its average volume of 10,686,054. The company has a market cap of $7.03 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock has a 50 day moving average price of $89.75 and a 200 day moving average price of $90.63.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.